Solid-phase extraction treatment is required for measurement of active glucagon-like peptide-1 by enzyme-linked immunosorbent assay kit affected by heterophilic antibodies.
Tomonori HasegawaMiho KomagataAkihiro HamasakiNorio HaradaYutaka SeinoNobuya InagakiPublished in: Journal of diabetes investigation (2018)
Substances absorbed to a heterophilic blocking tube carrier might interfere with an active GLP-1 immunoassay. Solid-phase extraction treatment is required for measurement of active GLP-1 by an ELISA kit affected by heterophilic antibodies.
Keyphrases
- solid phase extraction
- liquid chromatography tandem mass spectrometry
- molecularly imprinted
- high performance liquid chromatography
- simultaneous determination
- tandem mass spectrometry
- gas chromatography mass spectrometry
- gas chromatography
- high throughput
- drinking water
- high resolution
- combination therapy
- single cell
- replacement therapy
- sensitive detection
- smoking cessation
- label free